相关实验视频
Updated: Jul 23, 2025

13:28
Methodology for Sputum Induction and Laboratory Processing
Published on: December 17, 2017
27.7K
与过度使用沙布他在支气管炎中相关的因素
Marta Montejo1,2, Natalia Paniagua3,2, Jose Ignacio Pijoan4,5,2
1Rontegi-Barakaldo Primary Care Center, Basque Health Service - Osakidetza, Barakaldo, Spain.
European journal of pediatrics
|July 15, 2023
概括
在支气管炎管理中过度使用萨尔布塔摩尔仍然存在,尽管有质量改善的举措. 诸如年龄较大,较晚的季节访问和发作严重程度等因素与在初级保健和急诊机构的持续过度使用有关.
科学领域:
- 儿科呼吸系统医学 儿科呼吸系统医学
- 医疗保健服务研究 医疗服务研究
- 提高医疗保健的质量 改善医疗保健的质量
背景情况:
- 质量改善举措旨在减少支气管炎的非证据基础治疗.
- 这些举措对药物使用的影响可能会有所不同.
- 在支气管炎管理中过度使用萨尔布塔摩尔仍然是令人担忧的.
研究的目的:
- 为了确定与沙布塔摩尔过度使用相关的社会人口统计学和临床因素在患有支气管炎的儿童中.
- 在实施支气管炎综合护理途径 (BICP) 之前和之后分析这些因素.
主要方法:
- 在初级保健 (PC) 和急诊室 (ED) 进行前性队列研究的二次分析.
- 在两个支气管炎季节 (BICP实施前后) 收集的数据.
- 用于评估与萨尔布塔摩尔使用相关的因素的通用线性混合模型.
主要成果:
- 在PC和ED设置中确定了过度使用萨尔布塔摩尔的六个独立风险因素.
- 这些因素包括年龄≥1岁,季后访问,多次访问,全科医生咨询和发作的严重程度.
- 这些协会在BICP实施后继续存在.
结论:
- 特定的患者和临床因素与支气管炎管理中的持续过度使用沙布他有关.
- 质量改进举措可能无法完全消除这些处方模式.
- 需要进一步的有针对性的干预措施来解决这些持续因素.
相关概念视频
Antiasthma Drugs: β2-Adrenoceptor Agonists
311
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
311
COPD: Management Using Bronchodilators and Corticosteroids
249
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
249
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
348
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
348
Asthma-I: Introduction
2.7K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.7K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Drugs Used in Lower Respiratory Disorders: Overview
499
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
499

